BCL2 and neoplasm: Finally, to investigate the apoptotic response of primary tumor cells with TALEN-mediated mutant Trp53 gene after DOX treatment, the number of apoptotic cells, and the expression levels of Bax/Bcl-2 were measured in DOX treated CT26 cells, solid and ascetic primary tumor cells.